Early escalation from clopidogrel to new generation P2Y12 inhibitors is common practice in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). Real-world data about this strategy, however, are limited.
Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry
Capodanno, Davide;
2018-01-01
Abstract
Early escalation from clopidogrel to new generation P2Y12 inhibitors is common practice in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). Real-world data about this strategy, however, are limited.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2448967.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Dimensione
5.81 MB
Formato
Adobe PDF
|
5.81 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
